Team:Warsaw/Safety
From 2012.igem.org
Line 23: | Line 23: | ||
<li><a href="https://2010.igem.org/Team:Warsaw/Parts">Wet Lab</a></li> | <li><a href="https://2010.igem.org/Team:Warsaw/Parts">Wet Lab</a></li> | ||
<li><a href="https://2010.igem.org/Team:Warsaw/Software">Software</a></li> | <li><a href="https://2010.igem.org/Team:Warsaw/Software">Software</a></li> | ||
- | <li><a href="https:// | + | <li><a href="https://2012.igem.org/Team:Warsaw/Safety">Safety</a></li> |
<li><a href="https://2010.igem.org/Team:Warsaw/Team">Team</a></li> | <li><a href="https://2010.igem.org/Team:Warsaw/Team">Team</a></li> | ||
</ul> | </ul> | ||
Line 32: | Line 32: | ||
<li><a href="https://2010.igem.org/Team:Warsaw/Parts">Wet Lab</a></li> | <li><a href="https://2010.igem.org/Team:Warsaw/Parts">Wet Lab</a></li> | ||
<li><a href="https://2010.igem.org/Team:Warsaw/Software">Software</a></li> | <li><a href="https://2010.igem.org/Team:Warsaw/Software">Software</a></li> | ||
- | <li><a href="https:// | + | <li><a href="https://2012.igem.org/Team:Warsaw/Safety">Safety</a></li> |
<li><a href="https://2010.igem.org/Team:Warsaw/Team">Team</a> | <li><a href="https://2010.igem.org/Team:Warsaw/Team">Team</a> | ||
<div> | <div> | ||
Line 85: | Line 85: | ||
In our invasion device we use previously created listeriolysin BioBrick(BBa_...), which could be potentially harmful if someone was careless enough to get infected by a bacteria strain carrying this device. Even in this case the danger is limited as strains we use are unable to spread from cell to cell and it is impossible for them to last long in mammalian cells as it was mentioned before. We minimalized the risk by thorough application of our safety protocols.<br /><br /> | In our invasion device we use previously created listeriolysin BioBrick(BBa_...), which could be potentially harmful if someone was careless enough to get infected by a bacteria strain carrying this device. Even in this case the danger is limited as strains we use are unable to spread from cell to cell and it is impossible for them to last long in mammalian cells as it was mentioned before. We minimalized the risk by thorough application of our safety protocols.<br /><br /> | ||
- | 3. Is there a local biosafety group, committee, or review board at your institution?<br /> | + | <u>3. Is there a local biosafety group, committee, or review board at your institution?<br /></u> |
There are no local biosafety groups, committees or review boards at the Polish universities, but Polish Government issued a number of guidelines for conducting work with GMO and we are doing our best following them. All necessary permissions to work with GMO were obtained by the Department where we work. Concluding, all our laboratory work is in full agreement with appropriate law acts and nothing we do could be view as illegal.<br /><br /> | There are no local biosafety groups, committees or review boards at the Polish universities, but Polish Government issued a number of guidelines for conducting work with GMO and we are doing our best following them. All necessary permissions to work with GMO were obtained by the Department where we work. Concluding, all our laboratory work is in full agreement with appropriate law acts and nothing we do could be view as illegal.<br /><br /> | ||
</div> | </div> |
Revision as of 13:24, 6 September 2012
1. Would any of your project ideas raise safety issues in terms of: researcher safety, public safety, or environmental safety? Laboratory strains of E. coli and B. subtilis are not pathogenic, thus
not hazardous. Bacillus strain carrying a plasmid with listeriolysin
might be hazardous, so great care must be taken. But even if one does
become infected, this bacteria are unable of replicating and surviving
long inside mammalian cells. They are also incapable of spreading from
cell to cell, meaning that infection could not spread.
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? 3. Is there a local biosafety group, committee, or review board at your institution?
|